Our focus on the patient drives everything we do and as a result, our path forward is clear: to develop game-changing gene therapies for localized treatment of rare and serious diseases.
— John Maslowski, Chief Executive Officer
Applying the unique characteristics of autologous fibroblasts to gene therapies
Photo left: Courtesy of debra–The Dystrophic Epidermolysis Bullosa Research Association of America. Used with permission.
Photo right: Courtesy of debra–The Dystrophic Epidermolysis Bullosa Research Association of America. Used with permission.
